Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)

Market Cap	132.00B +166.7%
Revenue (ttm)	148.87B +39.1%
Net Income	16.90B +130.8%
EPS	3,380.00 +130.7%
Shares Out	5.00M
PE Ratio	7.81
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	6,501
Open	24,000
Previous Close	22,600
Day's Range	22,700 - 24,000
52-Week Range	8,100 - 24,000
Beta	0.69
RSI	79.64
Earnings Date	Apr 20, 2026

About HNX:MKV

Cai Lay Veterinary Pharmaceutical Joint Stock Company produces and trades in veterinary medicines in Vietnam and Indochina. The company offers Mekosal, a product for cattle, pets, fish, poultry, swine, and other animals through distributors and sales agents. It also engages in the production of premix, nutrients, and animal feed for livestock, poultry, and aquaculture; fishing for aquatic products and seafood; production, processing, and manufacturing of agricultural products; wholesale of fertilizers and plant seeds; breeding marine aquatic pr...

• Industry: Pharmaceutical Preparations
• Founded: 2003
• Employees: 104
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: MKV

Financial Performance

In 2025, HNX:MKV's revenue was 148.87 billion, an increase of 39.08% compared to the previous year's 107.04 billion. Earnings were 16.90 billion, an increase of 130.75%.